DOCSLIB.ORG

1. Te HS; Schiano TD; Kahaleh M; Lissoos TW; Baker AL; Hart J; Conjeevaram HS

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
1. Te HS; Schiano TD; Kahaleh M; Lissoos TW; Baker AL; Hart J; Conjeevaram HS 1. Te HS; Schiano TD; Kahaleh M; Lissoos TW; Baker AL; Hart J; Conjeevaram HS. Fulminant hepatic failure secondary to malignant melanoma: Case report and review of the literature. Am J Gastroenterol 1999, 94(1):262-6. 2. Francois E; Kahaleh M; Giovannini M; Matos C; Deviere J. EUS-guided pancreaticogastrostomy. Gastrointest Endosc. 2002;56(1):128-33. 3. Kahaleh M; Van Laethem JL; Nagy N; Cremer M; Deviere J. Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression. Endoscopy 2002,34 (12):950-955. 4. Kahaleh M; Hermans P; Buset M; Dargent JL. Primary Neutrophil-rich, CD30-positive large cell lymphoma of the stomach: case report and review of the literature. Acta Gastroenterol Belg. 2002;65(4):237-40. 5. Arseneau KO; Yeaton P; Kahaleh M; Cominelli F. Effect of digestive health care services integration on resources use and outcomes in patiens with digestive disorders. Clin Gastroenterol Hepatol. 2003 Mar;1(2):145-51. 6. Kahaleh M; Yoshida C; Yeaton P. EUS antegrade pancreatography with gastropancreatic duct stent placement: review of two cases Gastrointest Endosc. 2003;58(6):919-23. 7. Evrard S, Louis H, Kahaleh M, Zalcman M, Nagy N, El Nakadi I, Devière J. Idiopathic eosinophilic oesophagitis: atypical presentation of a rare disease. Acta Gastroenterol Belg. 2004;67(2):232-5. 8. Kahaleh M, Yoshida C, Kane L, Yeaton P. Endoscopic ultrasound drainage of a mediastinal abscess. Gastrointest Endosc 2004; 60(1):158-160. 9. Kahaleh M, Yoshida C, Kane L, Yeaton P. Interventional endoscopic ultrasound cholangiography. Report of five cases. Gastrointest Endosc 2004;60(1):138-142. 10. Kahaleh M, Hartwell GD, Arseneau KO, Pajewski TN, Mullick T, Isin G, Agarwal S, Yeaton P. Safety and Efficacy of ERCP in Pregnancy. Gastrointest Endosc 2004;60(2): 287-292. 11. Kahaleh M., Tokar J, Le T, Yeaton P. Removal of Self Expandable Metallic Wallstents. Gastrointest Endosc 2004;60(4): 647-651. 12. Kahaleh M, Tokar J, Mullick T, Bickston S, Yeaton P. Prospective Evaluation of Pancreatic Sphincterotomy as a Precut Technique for Biliary Cannulation. Clin Gastroenterol Hepatol 2004;2:971–977 13. Kahaleh M, Shami VM, Brock A, Yoshida C, Moskaluk CA, Adams RB, Tokar J, Yeaton P. Factors Predictive of Malignancy and Endoscopic Resectability in Ampullary Neoplasia. Am J Gastroenterol 2004;99:1-5. 14. Kahaleh M, Arseneau KO, Yeaton P. Safety and Efficacy of ERCP in Pregnancy. Gastrointest Endosc 2005;61(2):353 (invited letter) 15. Kahaleh M, Wang P, Shami VM, Tokar J, Yeaton P. EUS-guided Transhepatic Cholangiography: Preliminary Report of Six cases. Gastrointest Endosc 2005;61(2):307- 13 16. Kahaleh M, Wang P, Shami VM, Tokar J, Yeaton P. Endoscopic Ultrasound Drainage of Gallbladder Fossa Fluid Collections with Endoprosthesis Placement: A Preliminary Report of Two Cases. Endoscopy 2005; 37 (4):393-396. 17. Kahaleh M, Tokar J, Brock A, Le T, Adams R.B, Yeaton, P. Efficacy and Complications of Covered Wallstents in Malignant Distal Biliary Obstruction. Gastrointest Endosc 2005;61(4):528-533. 18. Nwakakwa V, Kahaleh M, Bennett A, Berg C, Brock A, Wick, M, Yeaton P. Endoscopic Mucosal Resection of Ampullary Gangliocytic Paragangliomas. Gastrointest Endosc 2005.;62(2):318-22. 19. Kane L, Kahaleh M, Shami VM, Caldwell S,Berg C, Abdrabbo K, Yoshida C, Arseneau K, Yeaton P. Comparison of the Detection of Esophageal Varices by Transnasal Endoluminal Ultrasound and Esophagogastroduodenoscopy. Clin Gastroenterol Hepatol 2005;3:806–810. 20. Kahaleh M, Shami VM, Tokar J, Rockoff T, de Lange E, Bassignani M, Gay S, Adams R.B, Yeaton P. Endoscopic Ultrasound Drainage of Pancreatic Pseudocyst: A Prospective Comparison with Conventional Endoscopic Drainage.Endoscopy 2006;38(4):355-9. 21. Kahaleh M, Hernandez AJ, Tokar J, Shami VM, Adams RB, Yeaton P. Interventional Endoscopic Ultrasound Cholangiography: Evaluation of a Technique in evolution. Gastrointest Endosc 2006;64(1):52-9. 22. Makola D, Krenitsky J, Parrish C, Dunston E, Shaffer HA,Yeaton P, Kahaleh M. Efficacy of enteral nutrition for the treatment of pancreatitis using standard enteral formula. Am J Gastroenterol 2006;101:2347–2355. 23. Policarpio-Nicolas M, Shami V,Kahaleh M, Adams R, Mallery S, Stanley M, Bardales R, Stelow E. Fine Needle Aspiration Cytology of Pancreatic Lymphoepithelial Cysts. Cancer. 2006;108(6):501-6. 24. Dumonceau J.M, Kahaleh M, Terraz S. Inadvertent Fracture of a Plastic Biliary Stent During a Combined Percutaneous-Endoscopic Procedure: A Word of Caution Regarding Self-Locking Pigtail Biliary Catheters. Cardiovasc Intervent Radiol. 2007;30(1):153-4 25. Kahaleh M, Hernandez AJ, Tokar J, Adams RB, Shami VM, Yeaton P. EUS-Guided Pancreaticogastrostomy: Analysis of its Efficacy to Drain Inaccessible Pancreatic Ducts.Gastrointest Endosc. 2007;65(2):224-30. 26. Jacobson BC, Shami VM, Faigel DO, Larghi A, Kahaleh M, Dye C, Pedrosa M, Waxman I. Through-the-Scope Balloon Dilation for Endoscopic Ultrasound Staging of Stenosing Esophageal Cancer. Dig Dis Sci. 2007.52(3):817-22. 27. Kahaleh M., Brock A, Conaway MR, Shami VM, Northup PG, Tokar JL, Rich TA, Adams RB, Yeaton P.Covered Self Expandable Metal Stents in Pancreatic Malignancy Regardless of Resectability: A New Concept Validated by a Decision Analysis. Endoscopy. 2007; 39(4):319-24. 28. Shami VM, Sundaram V, Stelow EB, Conaway M, Moskaluk CA, White GE, Adams RB, Yeaton P, Kahaleh M. The Level of Carcinoembryonic Antigen and the Presence of Mucus as Predictors of Cystic Pancreatic Mucinous Neoplasia. Pancreas 2007 May;34(4):466-9. 29. Kahaleh M. Antireflux Biliary Stent: Is it time to go with the flow? Gastrointest Endosc. 2007;65(6):829-31. (Editorial) 30. Kahaleh M, Sundaram V, Condron S, De La Rue SA, Hall JD, Tokar JL, Friel CM, Foley EF, Adams RB, Yeaton P. Placement of Covered Self Expandable Metallic Stents in Patients with Biliary Leak: Mid Term evaluation of a Pilot Study. Gastrointest Endosc 2007;66(1):52-9. 31. Shami VM, Kahaleh M. Endoscopic Ultrasonography (EUS)-Guided Access and Therapy of Pancreatico-Biliary Disorders: EUS-Guided Cholangio and Pancreatic Drainage.Gastrointest Endosc Clin N Am. 2007;17(3):581-93. 32. Hernandez A, Kahaleh M, Olazagasti J, Jones DR, Daniel T, Stelow E, White GE, Shami VM. EUS-FNA as the Initial Diagnostic Modality in Centrally Located Primary Lung Cancers. J Clin Gastroenterol. 2007;41(7):657-60. 33. McDonough PB, Jones DR, Shen KR, Northup PG, Galysh RL, Hernandez A, White GE, Kahaleh M, Shami VM. Does FDG-PET Add Information to EUS and CT in the Initial Management of Esophageal Cancer? A Prospective Single Center Study. Am J Gastroenterol. 2007; 10:102:1–5 34. Stelow EB, Shami VM, Abbott TE, Kahaleh M, Adams RB, Bauer TW, Debol SM, Abraham JM, Mallery S, Policarpio-Nicolas ML.The use of fine needle aspiration cytology for the distinction of pancreatic mucinous neoplasia. Am J Clin Pathol. 2008;129:67-74. 35. Shami VM, Talrejan JP, Mahajan A, Phillips MS, Yeaton P,Kahaleh M. EUS-Guided Drainage of Bilomas: a New Alternative? Gastrointest Endosc. 2008;67:136-40. 36. Kahaleh M, Behm B,Clarke BW, Brock A, Shami VM, De La Rue SA, Sundaram V, Tokar J, Adams RB, Yeaton P. Temporary Placement of Covered Self Expandable Metal Stents in Benign Biliary Strictures: a New Paradigm? Gastrointest Endosc 2008;67:446- 54. 37. Dumonceau J.M, Dumortier J, Deviere J, Kahaleh M, Ponchon T, Maffei M, Costamagna G.Transnasal EGD: Practice Survey and Impact of a Live Video Retransmission. Digestive and Liver Disease 2008 Dig Liver Dis. 2008 Sep;40:776-83 38. Kahaleh M, Mishra R, Shami VM, Northup PG, Berg CL, Bashlor P, Jones P, Ellen K, Weiss JR, Brenin CM, Kurth BE, Rich R, Adams RB, Yeaton P. Unresectable Cholangiocarcinoma: Comparison of Survival in BiliaryStenting Alone Versus Stenting With PhotodynamicTherapy. Clin Gastroenterol Hepatol 2008;6:290–297. 39. Phillips MS, Gosain S, Bonatti H, Friel CM, Ellen K, Northup PG, Kahaleh M. Enteral Stents for Malignancy: A Report of 46 Consecutive Cases over 10 years, with Critical Review of Complications. J of Gastrointestinal Surg 2008;12:2045-50. 40. Baisden JM, Kahaleh M, Weiss GR, Sanfey H, Moskaluk CA, Yeaton P, de Lange EE, Rich TAMultimodality Treatment With Helical Tomotherapy Intensity Modulated Radiotherapy, Capecitabine, and Photodynamic Therapy is Feasible and Well Tolerated in Patients With Hilar Cholangiocarcinoma. Gastrointest Cancer Res. 2008 Sep;2(5):219- 24. 41. Shami VM, Mahajan A, Sundaram V, Davis EM, Loch MM, Kahaleh M. EUS Staging is Adversely Affected by Placement of a Self Expandable Metal Stent (SEMS): Fact or fiction? Pancreas. 2008 Nov;37:396-8. 42. Talreja JP, Shami VM, Ku J, Morris TD, Ellen K, Kahaleh M.Transenteric drainage of pancreatic-fluid collections with fully covered self-expanding metallic stents (with video).Gastrointest Endosc. 2008 Dec;68:1199-203. 43. Sauer B, Talreja J, Ellen K, Ku J, Shami VM, Kahaleh M.Temporary placement of a fully covered self-expandable metal stent in the pancreatic duct for management of symptomatic refractory chronic pancreatitis: preliminary data (with videos).Gastrointest Endosc. 2008 Dec;68:1173-8. 44. Hall JD, Kahaleh M, White GE, Talreja J, Northup PG, Shami VM. Presence of Lymph Node Vasculature: A New EUS Criterion for Benign Nodes? Dig Dis Sci.2009;54:118-21 45. Kahaleh M."Cross-wired" biliary metal stents for malignant hilar strictures: a new window of opportunity? Gastrointest Endosc 2009;69:1361-2 46. Mahajan A, Ho HC, Behm B, Phillips MS, Shami VM, Ellen K, Rehan M, Schmitt TM, Kahaleh M.Temporary Placement of Fully Covered Self-Expandable Metal Stents (CSEMS) in Benign Biliary Strictures: Mid-term evaluation (with Video). Gastrointest Endosc 2009;70:303-9 47.
Load more

Recommended publications
  • Gastrointestinal Cancers a Multidisciplinary Approach to Screening, Diagnosis, and Treatment
    Second Annual Update on Gastrointestinal Cancers A Multidisciplinary Approach to Screening, Diagnosis, and Treatment Friday, September 27, 2013 7:00am – 4:10pm COURSE DIRECTORS K.S. Clifford Chao, MD Michel Kahaleh, MD, AGAF, FACG, FASGE P. Ravi Kiran, MBBS, MS, FRCS, FACS Tyvin Rich, MD, FACR LOCATION Columbia University Medical Center Bard Hall New York City Register Online www.columbiasurgerycme.org Second Annual Update on Gastrointestinal Cancers A Multidisciplinary Approach to Screening, Diagnosis, and Treatment OVERVIEW EDUCATIONAL OBJECTIVES This course consists of lectures, case It is intended that this Continuing presentations, and Q&A panels with Medical Education (CME) activity will lead expert faculty. The course is broken into to improved patient care. At the conclusion five sessions, each covering gastrointestinal of this activity, participants should be able to: cancer in a specific area of the GI tract. 1. Identify new technologies and modalities Speakers in each session will cover research in the screening, surveillance, and diagnosis and the latest standards of care including of relevant gastrointestinal cancers. new innovations for screening, diagnosis, and treatment modalities including radiation 2. Offer patients non-invasive, interventional, therapy, chemotherapy, and surgery. This medical, and surgical approaches in the course will increase participant familiariza- treatment of gastrointestinal cancers. tion with current guidelines and recommen- 3. Identify emerging new chemotherapy, dations, and focus on the multidisciplinary targeted therapy, and radiation therapy team involved in the care of patients with options and approaches in the treatment gastrointestinal cancers. of gastrointestinal cancers. IDENTIFIED PRACTICE GAP/ 4. Apply their enhanced understanding of EDUCATIONAL NEEDS the benefits of the multidisciplinary approach to the screening, diagnosis, Gastrointestinal cancers include several treatment, and palliation of patients with malignancies, including those of the gastrointestinal cancers.
    [Show full text]
  • Practice Patterns and Use of Endoscopic Retrograde
    Practice patterns and use of endoscopic retrograde cholangiopancreatography in the management of recurrent acute pancreatitis Qiang Cai, Emory University Field Willingham, Emory University Steven Keilin, Emory University Vaishali Patel, Emory University Parit Mekaroonkamol, Emory University JB Reichstein, Duke University S Dacha, Emory University Journal Title: Clinical Endoscopy Volume: Volume 53, Number 1 Publisher: (publisher) | 2019-01-01, Pages 73-81 Type of Work: Article Publisher DOI: 10.5946/ce.2019.052 Permanent URL: https://pid.emory.edu/ark:/25593/vhjfb Final published version: http://dx.doi.org/10.5946/ce.2019.052 Accessed September 27, 2021 7:02 AM EDT ORIGINAL ARTICLE Clin Endosc 2020;53:73-81 https://doi.org/10.5946/ce.2019.052 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Open Access Practice Patterns and Use of Endoscopic Retrograde Cholangiopancreatography in the Management of Recurrent Acute Pancreatitis Jonathan B. Reichstein1, Vaishali Patel2, Parit Mekaroonkamol2, Sunil Dacha2, Steven A. Keilin2, Qiang Cai2 and Field F. Willingham2 1Department of Medicine, Duke University, Durham, NC, 2Division of Digestive Disease, Department of Medicine, Emory University, Atlanta, GA, USA Background/Aims: There are conflicting opinions regarding the management of recurrent acute pancreatitis (RAP). While some physicians recommend endoscopic retrograde cholangiopancreatography (ERCP) in this setting, others consider it to be contraindicated in patients with RAP. The aim of this study was to assess the practice patterns and clinical features influencing the management of RAP in the US. Methods: An anonymous 35-question survey instrument was developed and refined through multiple iterations, and its use was approved by our Institutional Review Board.
    [Show full text]
  • Interventional Innovations in Digestive Care to Receive the Negotiated Group Rate
    The First Annual Peter D. Stevens Course on Interventional Innovations in Digestive Ca re Special Sessions: Hands-on Animal Tissue Labs, Live OR & Interventional Cases April 2 6–27, 2012 New York City Program Co-Directors: Michel Kahaleh, MD, AGAF, FACG, FASGE Robbyn Sockolow, MD, AGAF Marc Bessler, MD, FACS Jeffrey Milsom, MD, FACS, FACG www.gi-innovations.org Endorsed by This course is endorsed by the American Society for Endorsed by the Gastrointestinal Endoscopy AGA Institute Interventional Innov ations in Digestive Ca re n Overall Goals This two day course will inform participants of the latest innovations for the management of gastrointestinal diseases and disorders, and will offer a unique opportunity to learn more about the current trends in interventional endoscopic and surgical procedures. Internationally recognized faculty will address issues in current clinical practice, compli - cations and pitfalls of newer technologies, and the evolution of the field. Using a systems- based approach, the format will cover all major areas of digestive care and treatment options. Attendee participation and interaction will be emphasized and facilitated through Q & A sessions, live OR and interactive case presentations, hands-on animal tissue labs and meet the professor break-out sessions. n Learning Objectives • Understand endoscopic necrosectomy • Understand the use of ablation • Increase knowledge of the latest therapy for bile duct cancer innovations in minimally invasive • Learn the latest advances in techniques in bariatrics endoscopic
    [Show full text]
  • Endoscopic Ultrasound
    CLINICAL GASTROENTEROLOGY Series Editor George Y. Wu University of Connecticut Health Center, Farmington, CT, USA For further volumes: http://www.springer.com/series/7672 Endoscopic Ultrasound Edited by VANESSA M. SHA M I , MD Director of Endoscopic Ultrasound University of Virginia Health System Digestive Health Center, USA and MICHEL KAHALEH , MD Director of Pancreatico-Biliary Services University of Virginia Health System Digestive Health Center, USA Editors Vanessa M. Shami, MD Michel Kahaleh, MD Associate Professor of Medicine Associate Professor of Medicine Director of Endoscopic Ultrasound Director of Pancreatico-Biliary Services Digestive Health Center Digestive Health Center University of Virginia Health System University of Virginia Health System Charlottesville, VA, USA Charlottesville, USA [email protected] [email protected] ISBN 978-1-60327-479-1 e-ISBN 978-1-60327-480-7 DOI 10.1007/978-1-60327-480-7 Springer New York Dordrecht Heidelberg London Library of Congress Control Number: 2010930043 © Springer Science+Business Media, LLC 2010 All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Humana Press, c/o Springer Science+Business Media, LLC, 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks, and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights.
    [Show full text]
  • Stents for the Gastrointestinal Tract and Nutritional Implications
    NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #46 Carol Rees Parrish, R.D., M.S., Series Editor Stents for the Gastrointestinal Tract and Nutritional Implications Michelle Loch Michel Kahaleh Endoscopic stenting of many sites along the gastrointestinal tract is used successfully for palliation of malignant or benign obstructions. These obstructions may be the result of primary gastrointestinal tumors invading the lumen, tumors of another primary site causing external compression or in some instance benign diseases secondary to various inflammatory processes. Stenting of the gastrointestinal tract has been commonly per- formed either by interventional radiologists with the use of fluoroscopy, or by gas- troenterologists endoscopically, with or without fluoroscopic guidance. Their efficacy can be measured by resolution of obstruction or symptom improvement. The current literature shows that endoscopic stenting have acceptable success and complication rates and might be considered as first-line therapy in centers offering expertise in inter- ventional endoscopy. The techniques, efficacy and complication of stenting will be dis- cussed. Nutritional guidelines will also be provided based on our institutions practice. INTRODUCTION most current literature (Table 1) (4–9). Common causes ndoscopy within the last two decades has encom- of stent requirement to preserve nutritional status passed many interventional procedures allowing include esophageal, duodenal, biliary and colonic Ethe treatment of multiple conditions of the upper obstruction;
    [Show full text]
  • Endoscopic Palliation for Pancreatic Cancer
    Cancers 2011, 3, 1947-1956; doi:10.3390/cancers3021947 OPEN ACCESS cancers ISSN 2072-6694 www.mdpi.com/journal/cancers Review Endoscopic Palliation for Pancreatic Cancer Mihir Bakhru 1, Bezawit Tekola 2 and Michel Kahaleh 1,2,* 1 Division of Gastroenterology and Hepatology, University of Virginia, PO Box 800708, Charlottesville, VA 22908, USA; E-Mail: [email protected] (M.B.) 2 Division of Medicine, University of Virginia, PO Box 800708, Charlottesville, VA 22908, USA; E-Mail: [email protected] (B.T.) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-434-243-9259; Fax: +1-434-924-0491. Received: 1 March 2011; in revised form: 1 April 2011 / Accepted: 1 April 2011 / Published: 13 April 2011 Abstract: Pancreatic cancer is devastating due to its poor prognosis. Patients require a multidisciplinary approach to guide available options, mostly palliative because of advanced disease at presentation. Palliation including relief of biliary obstruction, gastric outlet obstruction, and cancer-related pain has become the focus in patients whose cancer is determined to be unresectable. Endoscopic stenting for biliary obstruction is an option for drainage to avoid the complications including jaundice, pruritus, infection, liver dysfunction and eventually failure. Enteral stents can relieve gastric obstruction and allow patients to resume oral intake. Pain is difficult to treat in cancer patients and endoscopic procedures such as pancreatic stenting and celiac plexus neurolysis can provide relief. The objective of endoscopic palliation is to primarily address symptoms as well improve quality of life. Keywords: pancreatic adenocarcinoma; biliary obstruction; gastric outlet obstruction; endoscopy; stents; palliation 1.
    [Show full text]
  • Management of Benign and Malignant Pancreatic Duct Strictures
    REVIEW Clin Endosc 2018;51:156-160 https://doi.org/10.5946/ce.2017.085 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Open Access Management of Benign and Malignant Pancreatic Duct Strictures Enad Dawod and Michel Kahaleh Division of Gastroenterology and Hepatology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY, USA The diagnosis and management of pancreatic strictures, whether malignant or benign, remain challenging. The last 2 decades have seen dramatic progress in terms of both advanced imaging and endoscopic therapy. While plastic stents remain the cornerstone of the treatment of benign strictures, the advent of fully covered metal stents has initiated a new wave of interest in calibrating the pancreatic duct with fewer sessions. In malignant disease, palliation remains the priority and further data are necessary before offering systematic pancreatic stenting. Clin Endosc 2018;51:156-160 Key Words: Pancreatic ducts; Pancreas; Fully covered metal stent; Cholangiopancreatography, endoscopic retrograde; Endosonography INTRODUCTION giopancreatography (ERCP) as the method of choice in ob- taining tissue specimen, as it is associated with a higher suc- Pancreatic duct stricture is a common problem that is asso- cess rate and fewer post-procedural complications.4 Pancreatic ciated with various etiologies. Benign etiologies include brushing should be employed in the absence of a definitive chronic pancreatitis, recurrent acute pancreatitis, trauma, sur- mass on imaging.3 Furthermore, repeat EUS has been shown gical complications, and pseudocysts. Pancreatic strictures can to improve diagnostic yield in the case of continued suspicion also be a manifestation of malignancy.1,2 The diagnosis and of cancer and to increase the sensitivity of pancreatic mass treatment of pancreatic strictures have proven challenging for detection in the setting of chronic pancreatitis.4,5 Confocal physicians.
    [Show full text]
  • Stent Placement As a Bridge to Surgery in Malignant Biliary Obstruction (Pancreatic Cancer, Distal Bile Duct Cancer, and Hilar Tumors)
    Gastrointest Interv 2015; -:1–6 Contents lists available at ScienceDirect Gastrointestinal Intervention journal homepage: www.gi-intervention.org Invited Review Article Stent placement as a bridge to surgery in malignant biliary obstruction (pancreatic cancer, distal bile duct cancer, and hilar tumors) Mario Rodarte-Shade, Michel Kahaleh* abstract Preoperative biliary drainage (PBD) has been a matter of controversy for years. It was initially aimed to improve the clinical status of patients with malignant obstructive jaundice prior to surgery. However, its efficacy and safety have not been proven by randomized controlled trials. Most drawbacks of PBD are related to the increase in procedure-related adverse events and inappropriate biliary decompression. Current trends in PBD show that using self- expanding metallic stents (SEMSs) may reduce the high incidence of stent-related complications with improved outcomes. The aim of this study was to review the current literature regarding PBD in patients with resectable distal pancreaticobiliary and hilar tumors. Copyright Ó 2015, Society of Gastrointestinal Intervention. Published by Elsevier. All rights reserved. Keywords: distal bile duct cancer, hilar tumor, malignant biliary obstruction, pancreatic cancer, preoperative biliary drainage Introduction review the existing literature concerning the use of PBD in patients with resectable distal pancreaticobiliary malignancies. Preopera- Malignant biliary obstruction encompasses a group of neo- tive biliary drainage in hilar tumor is also discussed separately. plasms that compromise bile duct flow and clinically presents with obstructive jaundice. Obstruction can be anatomically classified as Pathophysiology of biliary obstruction “distal” or “proximal.” Proximal bile duct obstruction refers to hilar bile duct cholangiocarcinomas (i.e., Klatskin tumors), whereas Biliary obstruction and cholestasis has several deleterious distal bile duct obstruction refers to periampullary tumors.
    [Show full text]
  • Diagnosis of Distal Cholangiocarcinoma After the Removal of Choledocholithiasis
    Hindawi Publishing Corporation Gastroenterology Research and Practice Volume 2012, Article ID 396869, 5 pages doi:10.1155/2012/396869 Clinical Study Diagnosis of Distal Cholangiocarcinoma after the Removal of Choledocholithiasis Yasuhiro Ito, 1 Takeshi Kenmochi, 1 Tomohisa Egawa,1 Shinobu Hayashi,1 Atsushi Nagashima,1 and Yuko Kitagawa2 1 Department of Surgery, Saiseikai Yokohamashi Tobu Hospital, 3-6-1 Shimosueyoshi, Tsurumi-ku, Yokohama-shi, Kanagawa 230-8765, Japan 2 Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan Correspondence should be addressed to Yasuhiro Ito, [email protected] Received 6 August 2012; Revised 16 October 2012; Accepted 18 October 2012 Academic Editor: Michel Kahaleh Copyright © 2012 Yasuhiro Ito et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background and Aim. Distal cholangiocarcinoma associated with choledocholithiasis has not been reported, and the causal relationship remains to be established. We evaluated diagnosis of distal cholangiocarcinoma diagnosed after the removal of choledocholithiasis. Patients and Methods. We assigned 9 cases of cholangiocarcinoma with choledocholithiasis to Group A. As a control group, 37 patients with cholangiocarcinoma without choledocholithiasis were assigned to Group B. Results. Abdominal pain at admission is the only significant difference between Group A and Group B (P = 0.001). All patients in Group A had gall bladder stones, compared with 7 patients (19%) in Group B (P<0.01). Of the 9 patients in Group A, endoscopic retrade cholangiopancreatography (ERCP) detected normality in 2 patients (22%) and abnormalities in 7 patients (78%).
    [Show full text]
  • Advanced-Endoscopy-Brochure.Pdf
    Advanced Endoscopy Services Division of Gastroenterology & Hepatology Clinical Academic Building, Fifth Floor 125 Paterson Street New Brunswick, NJ 08901 Phone: 732-235-7784 Cutting-edge techniques, groundbreaking research for a Our practice is a proud part of Rutgers Health , the clinical arm of Rutgers, The State University Advanced range of gastrointestinal issues of New Jersey. Rutgers Health is the most comprehensive academic From disease diagnosis to novel therapies health care provider in New Jersey, offering a Endoscopy breadth of accessible clinical care throughout the for treatment, our expert team of specialists state supported by the latest in medical research uses advanced and interventional endoscopic and education. Rutgers Health connects health techniques to meet the needs of individuals care providers across disciplines, including doctors, Services nurses, dentists, physician assistants, pharmacists, with a variety of gastrointestinal disorders, social workers, and behavioral health and addiction from gallstones to the most complex cancers professionals, with a single focus: helping people of the gastrointestinal tract. We provide and populations get well and stay well by delivering consistent, coordinated, value-based health care. minimally invasive alternatives to surgical or interventional radiology procedures, focusing on improved care and early detection and treatment of these conditions. Our dedicated, state-of-the-art endoscopy suite enables our specialists to easily Rutgers Health complies with applicable federal civil rights laws and integrate cutting-edge technology as they does not discriminate on the basis of race, color, national origin, age, disability or sex. Rutgers Health does not exclude people or treat perform the full range of highly advanced them differently because of race, color, national origin, age, disability or sex.
    [Show full text]
  • Study Protocol, Statistical Analysis Plan, and Informed
    COMIRB 19-0402 PI: Raj Shah Version Date: 8/12/19 1 Per-oral Pancreatoscopy-guided Lithotripsy vs. Extracorporeal Shock Wave Lithotripsy For Treating Symptomatic Main Pancreatic Duct Stones in Chronic Pancreatitis: A Multicenter Randomized Clinical Trial Contents Synopsis ..................................................................................................................................................................... 2 List of Abbreviations .................................................................................................................................................. 3 Study Protocol Including Research Questions/Hypothesis, Risks, and Benefits ................................................. 4-8 Research Questions and Hypothesis ..................................................................................................................... 4-5 Basic Design of the Study .................................................................................................................................... 5-8 Subject Inclusion and Exclusion Criteria ................................................................................................................. 7 Standard of Care/Research Procedure ...................................................................................................................... 9 Subject and Study Stopping Criteria ...................................................................................................................9-10 Data Collection Tool .............................................................................................................................................
    [Show full text]
  • (Cellvizio) Confocal Laser Endomicroscopy in Gastroenterology
    Review articles Utility of Probe-based (Cellvizio) Confocal Laser Endomicroscopy in Gastroenterology Elías Alfonso Forero Piñeros, MD,1 Héctor José Cardona, MD,2 Kunal Karia, MD,3 Amrita Sethi, MD,4 Michel Kahaleh, MD.5 1 Gastroenterologist and Chief of Gastroenterology and Abstract Endoscopy at the Central Police Hospital in Bogota, Colombia Probe based confocal laser endomicroscopy (Cellvizio Mauna Kea, Paris) is a new technology that allows per- 2 Gastroenterologist and Chief of Gastroenterology formance of histological analysis (optical biopsy) during any endoscopic procedure. This improves diagnosis and Hospital Simon Bolivar and GastroinvestSAS in and helps define the treatment needed for multiple digestive diseases. Its utility for diseases that are difficult Bogota, Colombia 3 Internist and Fellow in Endoscopy at Presbyterian to diagnose such as indeterminate biliary strictures and pancreatic cystic neoplasms is noteworthy. Early and Hospital and Weill Cornell Medical College at Cornell accurate diagnoses can be very difficult with currently available techniques, but they are exactly what are University in Ithaca, New York USA needed to determine whether or not expensive surgical treatments with great potential morbidity, for example 4 Gastroenterologist and interventional endoscopist at Columbia University in New York, New York USA the Whipple procedure, need to be performed. This review looks at the contribution that this technology can 5 Gastroenterologist, interventional endoscopist, Chief make in our country where it is now available for the diagnosis and study of digestive diseases. of Endoscopy and Professor of Clinical Medicine at Weill Cornell Medical College in Ithaca, New York USA Keywords ......................................... Confocal laser endomicroscopy, gastrointestinal cancer, early detection. Received: 08-09-14 Accepted: 21-07-15 Gastrointestinal cancer contributes significantly to ove- Neoplastic changes are usually accompanied by an rall cancer morbidity and mortality rates.
    [Show full text]